Discussion about this post

User's avatar
Neural Foundry's avatar

Excellent breakdown of what's shaping up to be a pivotal week. The Fed decision is baked in, but Powell's guidance will be key - any hint of pausing after this cut could spook markets. On the earnings front, Thursday's lineup with Apple, Amazon, and Merck is absolutely critical. MRK has been flying under the radar relative to tech, but their pipeline progress and capital disciplne make them one of the more interesting healthcare stories. The rotation out of defensives and into growth shows strong risk appetite, but as you noted, markets are overbought. If we get any disappointment from Big Tech or a hawkish Fed tone, that consolidation could come fast. Great analysis.

Expand full comment

No posts

Ready for more?